News
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
Baird analyst Eric Coldwell maintained Quest Diagnostics with an Outperform rating and raised the price target from $191 to $194. Evercore ISI Group analyst Elizabeth Anderson maintained the stock with an In-Line rating and raised the price target from $175 to $180.
Investor Day to be held in New York on March ... Write to [email protected] Quest Diagnostics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Participating in Investor Day Advance registration is required. To register for the event, please go to: Quest Diagnostics 2025 Investor Day Registration. A live webcast of the event will ...
Investor's Business Daily on MSN1d
'Safe Haven' Stock Quest Diagnostics Bounds Off 50-Day Line On Its Solid ReportQuest Diagnostics stock remains a "safe haven," an analyst said Tuesday after the company topped first-quarter expectations.
Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling. Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be ...
Quest Diagnostics Inc.'s stock fell 3.6% early ... products and services to both investment professionals and individual investors. These products and services are usually sold through license ...
We came across a bullish thesis on Quest Diagnostics Incorporated (DGX) on Substack by Magnus Ofstad. In this article, we ...
Laboratory operator Quest Diagnostics beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback